NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 388 filers reported holding NEKTAR THERAPEUTICS in Q3 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $6,940,000 | -84.2% | 142,133 | -65.6% | 0.08% | -84.6% |
Q1 2018 | $43,901,000 | +17.2% | 413,147 | -34.1% | 0.49% | +23.5% |
Q4 2017 | $37,461,000 | +32.0% | 627,279 | -46.9% | 0.40% | +26.6% |
Q3 2017 | $28,378,000 | +28.9% | 1,182,422 | +5.0% | 0.31% | +25.8% |
Q2 2017 | $22,008,000 | -14.9% | 1,125,750 | +2.2% | 0.25% | -16.2% |
Q1 2017 | $25,851,000 | +95.4% | 1,101,445 | +2.1% | 0.30% | +76.2% |
Q4 2016 | $13,233,000 | +2525.6% | 1,078,454 | +3578.1% | 0.17% | +1766.7% |
Q3 2016 | $504,000 | +23.8% | 29,321 | +2.5% | 0.01% | +28.6% |
Q2 2016 | $407,000 | – | 28,596 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Strong Tower Advisory Services | 404,972 | $6,913,000 | 4.02% |
GREAT POINT PARTNERS LLC | 504,691 | $9,064,000 | 2.11% |
Camber Capital Management LP | 3,750,000 | $67,350,000 | 2.07% |
ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,901,000 | 1.50% |
Rhenman & Partners Asset Management AB | 950,000 | $17,062,000 | 1.20% |
MAVERICK CAPITAL LTD | 5,838,426 | $104,858,000 | 1.06% |
Birchview Capital, LP | 72,000 | $1,293,000 | 0.88% |
Bellevue Group AG | 4,594,656 | $82,519,000 | 0.84% |
CM Management, LLC | 50,000 | $898,000 | 0.67% |
Duquesne Family Office | 1,000,000 | $17,960,000 | 0.58% |